Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Diabetes & Metabolism|July 7, 2025
Post-translational modifications of apolipoproteins as promising biomarkers for diabetes-related cardiovascular diseases: A comprehensive reviewChloé Chevalier, Arsênio Rodrigues Oliveira, Valentin Blanchard, et al.
Cardiovascular Diabetology|February 8, 2022
Plasma apolipoprotein concentrations and incident diabetes in subjects with prediabetesMikaël Croyal, Matthieu Wargny, Kevin Chemello, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 18, 2017
Stable Isotope Kinetic Study of ApoM (Apolipoprotein M)Mikaël Croyal, Stéphanie Billon-Crossouard, Sophie Goulitquer, et al.
Atherosclerosis|December 14, 2019
Circulating PCSK9 levels are not associated with the conversion to type 2 diabetesStéphane Ramin-Mangata, Matthieu Wargny, Matthieu Pichelin, et al.
Cardiovascular Research|July 27, 2021
The size of apolipoprotein (a) is an independent determinant of the reduction in lipoprotein (a) induced by PCSK9 inhibitorsValentin Blanchard, Kévin Chemello, Tim Hollstein, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 30, 2017
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of EvolocumabAurélie Thedrez, Dirk J Blom, Stéphane Ramin-Mangata, et al.
Journal of Lipid Research|March 16, 2018
Kinetics of plasma apolipoprotein E isoforms by LC-MS/MS: a pilot studyValentin Blanchard, Stéphane Ramin-Mangata, Stéphanie Billon-Crossouard, et al.
Diabetologia|January 7, 2021
Plasma concentrations of lipoproteins and risk of lower-limb peripheral artery disease in people with type 2 diabetes: the SURDIAGENE studyCapucine Bertrand, Pierre-Jean Saulnier, Louis Potier, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 21, 2020
VLDL (Very-Low-Density Lipoprotein)-Apo E (Apolipoprotein E) May Influence Lp(a) (Lipoprotein [a]) Synthesis or AssemblyMikaël Croyal, Valentin Blanchard, Khadija Ouguerram, et al.
JACC. Basic to Translational Science|July 3, 2020
Lipoprotein(a) Cellular Uptake Ex Vivo and Hepatic Capture In Vivo Is Insensitive to PCSK9 Inhibition With AlirocumabKévin Chemello, Sandra Beeské, Thi Thu Trang Tran, et al.
Pageof 3